Treatment of Severe Atopic Dermatitis (AD)
A new area of treatment options makes it possible to choose evidence-based drugs with a more favorable risk/benefit profile for patients with atopic dermatitis. According to Dr. Pedro Mendes-Bastos, we first must select the right, and most severely affected, patients. Secondly, we are to choose between drugs. Get his elaboration in this EADV 2022 MEDtalk.
Få tillgång
Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.
- Få tillgång
- Om du redan har en profil: Logga in